Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Goldstein

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Oncotarget|May 12, 2023
Targeting H3K27me3 loss in pediatric brain tumors - a perspective on epigenetically guided cancer therapyMichael Goldstein
Journal of Environmental Monitoring : JEM|May 12, 2007
Environmental forensics: the case for professional registrationMichael Goldstein
Child Development|August 26, 2025
The Dynamics of Perception in Caregiving: How Infants Change the Way We See the WorldEmma Murrugarra, Michael Goldstein
Optics Express|July 10, 2012
Actinic microscope for extreme ultraviolet lithography photomask inspection and reviewMichael Goldstein, Patrick Naulleau
Cancer Research|January 30, 2016
Small RNAs Recruit Chromatin-Modifying Enzymes MMSET and Tip60 to Reconfigure Damaged DNA upon Double-Strand Break and Facilitate RepairQinhong Wang, Michael Goldstein
Annual Review of Medicine|November 26, 2014
The DNA damage response: implications for tumor responses to radiation and chemotherapyMichael Goldstein, Michael B Kastan
Journal of Oncology Practice|September 28, 2010
Academic and Community-Based Cancer Centers: it's an Uncertain World and the Journal of Oncology Practice Will Follow it CloselySamuel M Silver, Michael Goldstein
Cancer Research|May 6, 2015
Repair versus Checkpoint Functions of BRCA1 Are Differentially Regulated by Site of Chromatin BindingMichael Goldstein, Michael B Kastan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?Rebecca A Miksad, Lowell Schnipper, Michael Goldstein
Toxicology and Applied Pharmacology|February 22, 2008
Apoptotic death induced by the cyclophosphamide analogue mafosfamide in human lymphoblastoid cells: contribution of DNA replication, transcription inhibition and Chk/p53 signalingMichael Goldstein, Wynand P Roos, Bernd Kaina
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Oncotarget|May 12, 2023
Targeting H3K27me3 loss in pediatric brain tumors - a perspective on epigenetically guided cancer therapyMichael Goldstein
Journal of Environmental Monitoring : JEM|May 12, 2007
Environmental forensics: the case for professional registrationMichael Goldstein
Child Development|August 26, 2025
The Dynamics of Perception in Caregiving: How Infants Change the Way We See the WorldEmma Murrugarra, Michael Goldstein
Optics Express|July 10, 2012
Actinic microscope for extreme ultraviolet lithography photomask inspection and reviewMichael Goldstein, Patrick Naulleau
Cancer Research|January 30, 2016
Small RNAs Recruit Chromatin-Modifying Enzymes MMSET and Tip60 to Reconfigure Damaged DNA upon Double-Strand Break and Facilitate RepairQinhong Wang, Michael Goldstein
Annual Review of Medicine|November 26, 2014
The DNA damage response: implications for tumor responses to radiation and chemotherapyMichael Goldstein, Michael B Kastan
Journal of Oncology Practice|September 28, 2010
Academic and Community-Based Cancer Centers: it's an Uncertain World and the Journal of Oncology Practice Will Follow it CloselySamuel M Silver, Michael Goldstein
Cancer Research|May 6, 2015
Repair versus Checkpoint Functions of BRCA1 Are Differentially Regulated by Site of Chromatin BindingMichael Goldstein, Michael B Kastan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?Rebecca A Miksad, Lowell Schnipper, Michael Goldstein
Toxicology and Applied Pharmacology|February 22, 2008
Apoptotic death induced by the cyclophosphamide analogue mafosfamide in human lymphoblastoid cells: contribution of DNA replication, transcription inhibition and Chk/p53 signalingMichael Goldstein, Wynand P Roos, Bernd Kaina
Pageof 9